many consumer groups feel that the country a ...

many consumer groups feel that the country a drug approval process is too easy and, as a result, too many drugs are approved that are later found to be unsafe. on the other hand, a number of industry lobbyists have pushed for a more lenient approval process so that pharmaceutical companies can get new drugs approved more easily and quickly. consider a null hypothesis that a new, unapproved drug is unsafe and an alternative hypothesis that a new, unapproved drug is safe. complete parts (a) through (d) below.\na. explain the risks of committing a type i or type ii error. choose the correct answer below\na. a type i error would be incorrectly failing to approve an unsafe drug. a type ii error would be incorrectly approving a safe drug\nb. a type i error would be incorrectly approving a safe drug. a type ii error would be incorrectly failing to approve an unsafe drug\nc. a type i error would be incorrectly approving an unsafe drug. a type ii error would be incorrectly failing to approve a safe drug\nd. a type i error would be incorrectly failing to approve a safe drug. a type ii error would be incorrectly approving an unsafe drug

Answer

# Brief Explanations: A Type - I error occurs when the null hypothesis is true but is rejected. Here, the null hypothesis is that a new, unapproved drug is unsafe. So, a Type - I error is incorrectly rejecting the null hypothesis, i.e., incorrectly approving an unsafe drug. A Type - II error occurs when the null hypothesis is false but is not rejected. So, a Type - II error is incorrectly failing to reject the null hypothesis, i.e., incorrectly failing to approve a safe drug. # Answer: C. A Type I error would be incorrectly approving an unsafe drug. A Type II error would be incorrectly failing to approve a safe drug.